Why is Warner Bros. Discovery splitting in two?
How will Amazon’s $20B Pennsylvania cloud investment affect AI?
What caused Tesla’s stock downgrades after Musk-Trump feud?
Why did OpenAI hit $10 billion in annual recurring revenue?
How will Trump’s National Guard deployment impact LA protests?
What are the effects of US-China trade talks in London?
Why is Apple redesigning iOS with 'Liquid Glass' interface?
Analyst Says NewAmsterdam Stock Has Over 100% Upside, Citing 90% Success Probability For Obicetrapib
benzinga.com/news/health-care/25/06/45841878/analyst-says-newamsterdam-stock-has-over-100-upside-citing-90-success-probability-for-obicetrapi
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) on Monday released topline data from pre-specified Alzheimer’s Disease biomarker analyses in the Phase 3 BROADWAY clinical trial.
The study was primarily designed to evaluate the efficacy of obicetrapib in lowering low-density lipoprotein…
This story appeared on benzinga.com, 2025-06-09 16:23:57.